Comparative effectiveness of moderate-intensity statin with ezetimibe therapy versus high-intensity statin monotherapy in patients with acute coronary syndrome: a nationwide cohort study

Comparative effectiveness of moderate-intensity statin with ezetimibe therapy versus high-intensity statin monotherapy in patients with acute coronary syndrome: a nationwide cohort study

Abstract The long-term outcome of first-line moderate-intensity statin with ezetimibe combination therapy for secondary prevention after percutaneous coronary intervention in patients with acute coronary syndrome (ACS) compared to high-intensity statin monotherapy remains elusive. The objective of t...

Full description

Bibliographic Details
Main Authors:	Ji-Yong Jang, Seonji Kim, Jaehyeong Cho, Sung-youn Chun, Seng Chan You, Jung-Sun Kim
Format:	Article
Language:	English
Published:	Nature Portfolio 2024-01-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-024-51310-5

Similar Items

Effect of moderate-intensity statin with ezetimibe combination vs. high-intensity statin therapy according to sex in patients with atherosclerosis
by: Byung Gyu Kim, et al.
Published: (2023-11-01)

Statin and Ezetimibe Combination Therapy Decreases Mean Platelet Volume Compared to Statin Monotherapy
by: Jun-beom Lee, et al.
Published: (2017-01-01)

Intensive statin versus low-dose statin + ezetimibe treatment for fibrous cap thickness of coronary vulnerable plaques
by: Pei-Na Meng, et al.
Published: (2020-10-01)

Comparative Efficacy and Safety of Statin Monotherapy and Statin plus Ezetimibe Combination in a Real-World Setting
by: Marat V. Ezhov, et al.
Published: (2023-11-01)

Response by sex to statin plus ezetimibe or statin monotherapy: A pooled analysis of 22,231 hyperlipidemic patients
by: Lin Jianxin, et al.
Published: (2011-08-01)

Efficacy and safety of moderate-intensity statin with ezetimibe combination therapy in patients after percutaneous coronary intervention: a post-hoc analysis of the RACING trialResearch in context
by: Jong-Il Park, et al.
Published: (2023-04-01)

Efficacy of combination therapy with ezetimibe and statins versus a double dose of statin monotherapy in participants with hypercholesterolemia: a meta-analysis of literature
by: Min Yu, et al.
Published: (2020-01-01)

Effect of Combination Therapy with Ezetimibe and Statins versus Statin Monotherapy on Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Ryuk Jun Kwon, et al.
Published: (2023-11-01)

Intensive Statin Therapy Versus Upfront Combination Therapy of Statin and Ezetimibe in Patients With Acute Coronary Syndrome: A Propensity Score Matching Analysis Based on the PL‐ACS Data
by: Joanna Lewek, et al.
Published: (2023-09-01)

Similar major cardiovascular outcomes between pure statin and ezetimibe-statin in comparable intensity for type 2 diabetes with extremely atherosclerotic risks
by: Yu-Cheng Kao, et al.
Published: (2021-03-01)

Comparative Analysis of High-Intensity versus Low-to-Moderate Intensity Statin Therapy in Patients Undergoing Rotational Atherectomy for Calcified Coronary Artery Disease
by: Sang-Suk Choi, et al.
Published: (2023-11-01)

Comparison of statin plus ezetimibe with double-dose statin on lipid profiles and inflammation markers
by: Na-Qiong Wu, et al.
Published: (2018-11-01)

Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia
by: Ian Hamilton-Craig, et al.
Published: (2010-11-01)

The combination of Ezetimibe and Statin: a new treatment for hypercholesterolemia
by: Livio Dei Cas, et al.
Published: (2009-08-01)

Combination therapy in cholesterol reduction: focus on ezetimibe and statins
by: Liliana Grigore, et al.
Published: (2008-04-01)

Does the addition of ezetimibe to statins reduce cardiovascular risk?
by: Francisca I Araya, et al.
Published: (2016-12-01)

Expanding the therapeutic landscape: ezetimibe as non-statin therapy for dyslipidemia
by: Jeongmin Lee, et al.
Published: (2023-11-01)

Upfront Combination of Statin and Ezetimibe for Patients With Acute Coronary Syndrome: Time for a New Approach?
by: Lina Ya'Qoub, et al.
Published: (2023-09-01)

Moderate-intensity versus high-intensity statin therapy in Korean patients with angina undergoing percutaneous coronary intervention with drug-eluting stents: A propensity-score matching analysis.
by: Mahn-Won Park, et al.
Published: (2018-01-01)

Impact of combination therapy with statin and ezetimibe on secondary prevention for post-acute myocardial infarction patients in the statin era
by: Soichiro Ebisawa, et al.
Published: (2015-09-01)

Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy
by: Foody JM, et al.
Published: (2013-11-01)

Effect of Two Intensive Statin Regimens on Progression of Coronary Disease
Published: (2011-12-01)

ESCADRA: a randomised study. Part I: lipid-lowering effectiveness, safety and tolerability of ezetimibe, initial doses of original statins, and the combination of ezetimibe with initial doses of statins in patients with coronary heart disease and hyperlipidemia
by: M. Yu. Zubareva, et al.
Published: (2010-12-01)

Phenotyping of Korean patients with better-than-expected efficacy of moderate-intensity statins using tensor factorization.
by: Jingyun Choi, et al.
Published: (2018-01-01)

Cardiovascular events in patients received combined fibrate/statin treatment versus statin monotherapy: Acute Coronary Syndrome Israeli Surveys data.
by: Alexander Tenenbaum, et al.
Published: (2012-01-01)

45. Ezetimibe and statins yields on silent holter ambulatory myocardial ischemia
by: W. Kadro
Published: (2016-07-01)

Statin Intensity and Clinical Outcome in Patients with Stable Coronary Artery Disease and Very Low LDL-Cholesterol.
by: Soo Youn Lee, et al.
Published: (2016-01-01)

Re-Evaluation of Efficacy of Moderate-Intensity Statins in Korean Patients with Type 2 Diabetes Mellitus
by: Soo Kyoung Kim
Published: (2017-02-01)

Expert consensus on intensive statin therapy for patients with acute coronary syndrome
by: Yong Huo, et al.
Published: (2016-01-01)

The efficacy and safety of statin in combination with ezetimibe compared with double-dose statin in patients with high cardiovascular risk: A meta-analysis
by: Yunyun Zhu, et al.
Published: (2020-05-01)

Ineffective statin monotherapy: alternative therapeutic strategy
by: I. V. Sergienko
Published: (2011-08-01)

Cost-effectiveness of lowering LDL cholesterol with statins and ezetimibe in chronic kidney disease
by: Mihaylova, B, et al.
Published: (2019)

Effect of plant sterols compared with ezetimibe on oxidative stress in patients treated with statins
by: Adriana Bertolami, et al.
Published: (2014-09-01)

Clinical impact of statin intensity according to age in patients with acute myocardial infarction
by: Kyusup Lee, et al.
Published: (2022-01-01)

Clinical impact of statin intensity according to age in patients with acute myocardial infarction.
by: Kyusup Lee, et al.
Published: (2022-01-01)

Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus
by: Sung Hye Kong, et al.
Published: (2017-01-01)

High‐Intensity Versus Non‐High‐Intensity Statins in Patients Achieving Low‐Density Lipoprotein Cholesterol Goal After Percutaneous Coronary Intervention
by: Juwon Kim, et al.
Published: (2018-11-01)

The annual rate of coronary artery calcification with combination therapy with a PCSK9 inhibitor and a statin is lower than that with statin monotherapy
by: Yuichi Ikegami, et al.
Published: (2018-06-01)

Factors Associated with the Prescribing of High-Intensity Statins
by: Armando Chaure-Pardos, et al.
Published: (2020-11-01)

Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open-label, randomized clinical trial
by: Yu Chih-Chieh, et al.
Published: (2012-05-01)